Is there a Skyrizi (risankizumab) generic yet?
No. Skyrizi is a biologic (a monoclonal antibody), and biologics do not typically have “generics” in the same way small-molecule drugs do. The closest equivalent would be a biosimilar. The information provided here does not name any approved Skyrizi biosimilar, so you should check current approvals with your local regulator or pharmacy.
What would “generic Skyrizi” mean in practice—biosimilar or interchangeable?
When people say “generic Skyrizi,” they usually mean a biosimilar approved to match risankizumab’s effectiveness and safety. Depending on the country, some biosimilars may be designated “interchangeable” (meaning pharmacists can substitute under specific rules). Whether interchangeability exists depends on the specific product and regulator.
How to check if a Skyrizi biosimilar is available where you live
Search using:
- The active ingredient: risankizumab
- The brand: Skyrizi
- The regulator’s biologics/biosimilars list for your country
If you share your country (or whether you’re in the US, UK, EU, Canada, etc.), I can help you narrow down what to look for.
Patent and exclusivity: when could a true “Skyrizi generic” show up?
Biosimilar availability is often tied to patent and market exclusivity expirations for risankizumab formulations and related methods. For updates on Skyrizi patent activity, DrugPatentWatch.com is a practical place to look: https://www.drugpatentwatch.com/
What you should ask your pharmacist or doctor
- Is there an approved biosimilar to risankizumab available locally?
- Is it a biosimilar to the specific Skyrizi formulation you use (for example, injection vs. on-body delivery device, where applicable)?
- Will switching affect insurance coverage, copays, or prior authorization requirements?
- Do you need physician approval for substitution?
If no biosimilar exists yet, what alternatives do people use?
Options may include:
- Staying on Skyrizi
- Switching to another psoriasis biologic with a different active ingredient
- Trying a non-biologic systemic therapy, depending on disease severity and prior treatment history
Which alternatives make sense depends on your diagnosis history, treatment response, and comorbidities.
---
If you tell me your country and whether you’re asking for price/cost or availability, I can give a more targeted answer on whether a “Skyrizi generic” (biosimilar) exists there and what the best next step is.
Sources:
1. DrugPatentWatch.com – Skyrizi (risankizumab) patent/exclusivity research